Strategies for Innovation and Competitive Advantage

Bianca Piachaud

Chapter 3 in Outsourcing of R&D in the Pharmaceutical Industry, 2004, pp 56-85 from Palgrave Macmillan

Abstract: Abstract For a number of years, pharmaceutical companies have departed from a tradition of strict vertical integration so as to gain access to external sources of technology and expertise for the purpose of product and technological development. It is therefore necessary to examine the strategies employed by pharmaceutical companies at both the firm and industry level. To this end, particular emphasis must be placed on strategies of collaboration and co-operation between pharmaceutical firms and external agents given that a rise in such activity follows the trend of the wider industrial community.

Keywords: Competitive Advantage; Pharmaceutical Industry; Pharmaceutical Company; Joint Venturis; Strategic Alliance (search for similar items in EconPapers)
Date: 2004
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-51263-4_4

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230512634

DOI: 10.1057/9780230512634_4

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().